Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
17.63
+2.55 (16.91%)
At close: Oct 28, 2025, 4:00 PM EDT
18.60
+0.97 (5.50%)
After-hours: Oct 28, 2025, 7:57 PM EDT

Nanobiotix Revenue

Nanobiotix had revenue of 26.64M EUR in the half year ending June 30, 2025, with 708.93% growth. This brings the company's revenue in the last twelve months to 10.16M, down -75.93% year-over-year. In the year 2024, Nanobiotix had annual revenue of -7.19M, down -119.86%.

Revenue (ttm)
10.16M EUR
Revenue Growth
-75.93%
P/S Ratio
72.95
Revenue / Employee
94,065 EUR
Employees
108
Market Cap
870.31M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024-7.19M-43.40M-119.86%
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M322.00K13.85%
Dec 31, 20202.33M-216.00K-8.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings